000 01885 a2200505 4500
005 20250517082326.0
264 0 _c20160928
008 201609s 0 0 eng d
022 _a1471-2334
024 7 _a10.1186/s12879-016-1432-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSingh, Ramandeep
245 0 0 _aThe impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study.
_h[electronic resource]
260 _bBMC infectious diseases
_cFeb 2016
300 _a90 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aAsymptomatic Diseases
650 0 4 _aBacteriuria
_xdiagnosis
650 0 4 _aControlled Before-After Studies
650 0 4 _aCystitis
_xdiagnosis
650 0 4 _aDrug Resistance, Bacterial
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aKidney Transplantation
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPneumocystis carinii
650 0 4 _aPneumonia, Pneumocystis
_xetiology
650 0 4 _aPostoperative Complications
_xdiagnosis
650 0 4 _aPyelonephritis
_xdiagnosis
650 0 4 _aRetrospective Studies
650 0 4 _aTransplantation, Homologous
650 0 4 _aTreatment Outcome
650 0 4 _aTrimethoprim, Sulfamethoxazole Drug Combination
_xtherapeutic use
700 1 _aBemelman, Frederike J
700 1 _aHodiamont, Caspar J
700 1 _aIdu, Mirza M
700 1 _aTen Berge, Ineke J M
700 1 _aGeerlings, Suzanne E
773 0 _tBMC infectious diseases
_gvol. 16
_gp. 90
856 4 0 _uhttps://doi.org/10.1186/s12879-016-1432-3
_zAvailable from publisher's website
999 _c25767109
_d25767109